Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CMN571 > Module 1 Vaccinations > Flashcards

Module 1 Vaccinations Flashcards

1
Q

Hepatitis B (ages)

A

Birth, 1-2MO, 6-18MO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hepatitis B - how many doses are given of this vaccine?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rotavirus - types of “dose” series

A

RV1 Rotarix = 2 dose series (2 and 4 months)
RV5 Rotateq = 3 dose series (2, 4, 6 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rotavirus (ages) - 2 dose series

A

2MO, 4MO,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rotavirus (ages) - 3 dose series

A

2MO, 4MO, 6MO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications of rotavirus vaccination
(3)

A

-Severe allergic reaction (anaphylaxis) after previous dose or to vaccine component
-Severe combined immunodeficiency (SCID)
-History of intussusception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Contraindications of Hepatitis B
(2)

A

-Severe allergic reaction (anaphylaxis) after a pervious dose or to a vaccine component (including yeast)
-Pregnancy (Heplisav-B and PreHevbrio are not recommended due to lack of safety data in pregnant persons. Use other hepatitis B vaccines if HepB is indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How many doses of Rotavirus vaccinations are given?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dtap (ages)

A

2MO, 4MO, 6MO, 15-18MO, 4-6YR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many doses of Dtap are given?

A

5 doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Haemophilus influenzae type b (Hib) (ages & name) - 4 dose series

A

2MO, 4MO, 6MO; booster 12-15MO
ActHIB, Hiberix, Pentacel, or Vaxelis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Haemophilus influenzae type b (Hib) (ages & name) - 3 dose series

A

2MO, 4MO; booster 12-15MO
PedvaxHIB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Contraindications for Haemophilus influenzae type b (Hib)
(3)

A

-Severe allergic reaction (anaphylaxis) after a previous dose or to a vaccine component
-For Hiberix, ActHib, and PedvaxHIB only: history of severe allergic rxn to dry natural latex
-Age <6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Precautions for Haemophilus influenzae type b (Hib)
(1)

A

Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pneumococcal conjugate (ages, names of vaccine)

A

-2MO, 4MO, 6MO, 12-15MO
-PCV13 & PCV15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Contraindications for pneumococcal conjugate (2)

A

-severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component
-severe allergic rxn (anaphylaxis) to any diphtheria-toxoid-containing vaccine or its component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Precautions for pneumococcal conjugate (PCV) (1)

A

Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Inactivated Poliovirus (IPV) (ages & information on final dose)

A

2MO, 4MO, 6-18MO, 4-6YR
*administer final dose on or after age 4 years and at least 6MO after the previous dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

IPV number of doses

A

4 or more doses can be administered before age 4 years when a combination vaccine containing IPV is used
-however, a dose is still recommended on or after age 4 years and at least 6 months after the previous dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

COVID-19 (ages)

A

2- or 3- primary series and booster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

COVID-19 vaccine types/names/options

A

-mRNA: Moderna, Bivalent; Pfizer-BioNTech, Bivalent
-Protein subunit vaccine: novavax, Adjuvanted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

COVID-19 (ages for both Moderna and Pfizer-BioNTech and how many doses per series)

A

-6MO-4 years –> 2 dose series at 0, 4-8 weeks (Moderna) or 3 dose series at 0, 3-8, 11-16 weeks (Pfizer)
-5-11 years –> 2-dose series at 0, 4-8 weeks (Moderna) or 2-dose series at 0, 3-8 weeks (Pfizer)
-12-18 years –> 2-dose series at 0, 4-8 weeks (Moderna) or 2-dose series at 0, 308 weeks (Novavax, Pfizer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Influenza IIV4 and LAIV4 (ages, doses)

A

-minimum age: 6MO (IIV), 2 years (LAIV4), 18 years (recombinant influenza vaccine, RIV4)
-2 doses separated by at least 4 weeks, for children age 6 months-8 years who have received fewer than 2 influenza vaccine doses before July 1, 2022, or whose influenza vaccination history is unknown (administer dose 2 even if the child turns 9 between receipt of dose 1 and dose 2)
-1 dose for children age 6MO-8 years who have received at least 2 influenza vaccines before July 1, 2022
-1 dose for all persons age 9 years or older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Measles, mumps, rubella (MMR) (ages, # of doses)

A

*Minimum age is 12 months for routine vaccination
-2 dose series at age 12-15MO, age 4-6YR
-MMR or MMRV may be administered
*For dose 1 in children 12-47 months, it is recommended to administer MMR and varicella vaccines separately. MMRV may be used if parents or caregivers express a preference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Varicella (VAR) (ages, # of doses)

A

*Minimum age: 12MO
-2 dose series at age 12-15MO, 4-6YR
-VAR or MMRV may be administered
-Dose 2 may be administered as early as 3 months after dose 1 (a dose inadvertently administered after at least 4 weeks may be counted as valid
*For dose 1 in children age 12-47 months, it is recommended to administer MMR and varicella vaccines separately. MMRV may be used if parents or caregivers express a preference.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hepatitis A (HepA) (ages, # of doses)

A

*Minimum age: 12 months for routine vaccination
-2 doses series (minimum interval: 6 months) at age 12-23 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Tetanus, diphtheria, and acellular pertussis (Tdap) (ages, # of doses)

A

-*Minimum age: 11 years for routine vaccination, 7 years for catch-up vaccination
-Adolescents age 11-12 years: 1 dose Tdap
-Pregnancy: 1 dose Tdap during each pregnancy, preferably in early part of gestational weeks 27-36
-Tdap may be administered regardless of the interval since the last tetanus- and Diphtheria-toxoid-containing vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Human papillomavirus (HPV) (ages, # of doses)

A

*Minimum age: 9 years
-HPV vaccination routinely recommended at age 11-12 years (can start at age 9 years) and catch-up HPV vaccination recommended for all persons through age 18 years if not adequately vaccinated
-2 or 3-dose series depending on age at initial vaccination
–>age 9-14 years at initial vaccination: 2 dose series at 0, 6-12 months (minimum internal: 5 months; repeat dose if administered too soon)
–> age 15 years or older at initial vaccination: 3 dose series at 0, 1-2 months, 6 months to dose 3: 5 months; repeat dose if administered too soon
*if vaccination schedule interrupted, does not need to be restarted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Meningococcal (MenACWY-D: >=9MO, MenACWY-CRM: >=2MO, MenACWY-TT>=2YRs) (ages, # of doses)

A

-2 dose series at age 11-12 years; 16 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Pneumococcal polysaccharide (PPSV23) (ages, # of doses)

A

*Minimum age: 6 weeks (PCV13, PCV15) and 2 years PPSV23)
-4 dose series at 2, 4, 6, 12-15MO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Dengue (DEN4CYD: 9-16YRs) (age, # of doses)

A

*Minimum age: 9 years
-age 9-16 years living in areas with endemic dengue AND have laboratory confirmation of previous dengue infection
-3 dose series administered at 0, 6, and 12 months
-Endemic areas: Puerto Rico, American Samoa, US Virgin Islands, Federated States of Micronesia, Republic of Marshall Islands, and the Republic of Palau
*Dengue vaccine should not be administered to children traveling to or visiting endemic dengue areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Hepatitis B - Mother is HBsAg-positive

A

-Birth dose (monovalent HepB vaccine only): administer HepB vaccine and hepatitis B immune globulin (HBIG) (in separate limbs) within 12 hours of birth, regardless of birth weight
-birth weight <2000g: administer 3 additional doses of HepB vaccine beginning at age 1 month (total of 4 doses)
-Final (3rd or 4th) dose: administer at age 6 months (minimum age 24 weeks)
-Test for HBsAg and anti-HBs at age 9-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Hepatitis B - Mother is HBsAg-unknown

A

*manage infant as if mother is HBsAg-positive
-Birth dose: birth weight >=2000g - administer HepB vaccine w/i 12 hours of birth; if mother is determined HBsAg-positive, administer HBIG ASAP (in separate limb), but no later than 7 days of age. Birth weight <2000g - administer HepB vaccine and HBIG (in separate limbs) w/i 12 hours of birth; administer 3 additional doses of HepB vaccine beginning at age 1 month (total of 4 doses)
-Final (3rd or 4th) dose: administer at age 6 months (minimum age 24 weeks)
*If mother is determined to be HBsAg-positive or unknown, test for HBsAg and anti-HBs at age 9-12 months. If HepB series is delayed, test 1-2 months after final dose. Do not test before age 9 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Contraindications for Dengue (DEN4CYD)
(3)

A

-Severe allergic rxn (anaphylaxis) after previous dose or to a vaccine component
-Severe immunodeficiency (hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, long-term immunosuppressive therapy or patients with HIV infection who are severely immunocompromised
-Lack of laboratory confirmation of a previous Dengue infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Precautions of Dengue (DEN4CYD)
(3)

A

-Pregnancy
-HIV infection without evidence of severe immunosuppression
-Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Contraindications for DTap and DT
(2)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component
-For DTap only: encephalopathy (i.e. coma, dec level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTP or DTaP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Precautions for DTaP and DT
(4)

A

-Guillain-Barre syndrome (GBS) within 6 weeks after previous dose of tetanus-toxoid-containing vaccine
-History of Arthus-type hypersensitivity rxns after a previous dose of diphtheria-toxoid-containing or tetanus-toxoid containing vaccine; defer vaccination until at least 10 years have elapsed since the last tetanus-toxoid-containing vaccine
-For DTaP only: progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, progressive encephalopathy; defer DTaP until neurologic status clarified and stabilized
-Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Contraindications for Hepatitis A
(1)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component including neomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Precautions for Hepatitis A
(1)

A

-Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Precautions for Hepatitis B
(1)

A

-Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Contraindications for Hepatitis A- Hepatitis B vaccine (HepA-HepB, Trinrix)
(1)

A

Severe allergic rxn (anaphylaxis) after previous dose or two a vaccine component including neomycin and yeast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Precautions for Hepatitis A- Hepatitis B vaccine (HepA-HepB, Trinrix)
(1)

A

-Moderate or severe acute illness with or without fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Contraindications for HPV
(2)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component
0Pregnancy: HPV vaccination not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Precautions for HPV
(1)

A

Moderate or severe acute illness with or without fever

45
Q

Contraindications for MMR
(4)

A

-Severe allergic fxn (anaphylaxis) after a previous dose or to a vaccine component
-Severe immunodeficiency (hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, long-term immunosuppressive therapy or patients with HIV infection who are severely immunocompromised
-Pregnancy
-Family hx of altered immunocompetence, unless verified clinically or by laboratory testing as immunocompetent

46
Q

Precautions for MMR
(5)

A

-Recent (<=11 months) receipt of antibody-containing blood products (specific interval depends on product)
-History of thrombocytopenia or thrombocytopenic purpura
-Need for tuberculin skin testing or interferon-gamma release assay (IGRA) testing
-Moderate or severe acute illness with or without fever
-For MMRV only: personal or family (sibling or parent,) hx of seizures of any etiology

47
Q

Contraindications of Meningococcal ACWY
(3)

A

Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component
-For MenACWY-D and Men ACWY-CRM only: severe allergic rxn to any diphtheria toxoid- or CRM - containing vaccine
-For MenACWY-TT only: severe allergic rxn to a tetanus toxoid-containing vaccine

48
Q

Precautions for meningococcal ACWY
(3)

A

-For MenACWY-CRM only: preterm birth if less than age 9 months
-Moderate or severe acute illness with or without fever

49
Q

Contraindications for Meningococcal B (MenB), (Bexsero), (Trumenba)
(1)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component

50
Q

Precations for Meningococcal B (MenB), (Bexsero), (Trumenba)
(3)

A

-Pregnancy
-For MenB-4C only; Latex sensitivity
-Moderate or severe acute illness with or without fever

51
Q

Contraindications for PCV
(2)

A

-Severe allergic rxn (anapylasis) after a previous dose or to a vaccine component
-Severe allergic rxn (anaphylaxis) to any diphtheria-toxoid-containing vaccine or its component

52
Q

Precautions for PCV

A

-Moderate or severe acute illness with or without fever

53
Q

Contraindications for pneumococcal polysaccharide (PPSV23)
(1)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component

54
Q

Precautions for Pneumocococcal polysaccharide (PPSV23)
(1)

A

Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component

55
Q

Contraindications for poliovirus vaccine (IPV)
(1)

A

-severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component

56
Q

Precautions for poliovirus vaccine (IPV)
(2)

A

-Pregnancy
-Moderate or severe acute illness with or without fever

57
Q

Precautions for rotavirus
(4)

A

-Altered immunocompetence other than SCID
-Chronic gastrointestinal disease
-RV1 only: spina bifida or bladder exstrophy
-Moderate or severe acute illness with or without fever

58
Q

Contraindications for Tdap and Td
(2)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component
-For Tdap only: Encephalopathy (coma, decreased level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTP, DTaP, or Tdap

59
Q

Precautions for Tdap and Td
(4)

A

-Guillain-Barre syndrome (GBS) within 6 weeks after a previous dose of tetanus-toxoid-containing vaccine
-History of Arthus-type hypersensitivity reactions after a previous dose of diphtheria-toxoid-containing vaccine; defer vaccination until at least 10 years have elapsed since the last tetanus-toxoid-containing vaccine
-For Tdap only: progressive or unstable neurological disorder, uncontrolled seizures, or progressive encephalopathy until a treatment regimen has been established and the condition has stabilized
-Moderate or severe acute illness with or without fever

60
Q

Contraindications for Varicella (VAR)
(4)

A

-Severe allergic rxn (anaphylaxis) after a previous dose or to a vaccine component
-Severe immunodeficiency (hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, long-term immunosuppressive therapy or patients with HIV infection who are severely immunocompromised
-Pregnancy
-Family hx of altered immunocompetence, unless verified clinically or by laboratory testing as immunocompetent

61
Q

Precautions for Varicella (VAR)
(5)

A

-Recent (<=11months) receipt of antibody-containing blood product (specific interval depends on product)
-Receipt of specific antiviral drugs (acyclovir, famciclovir, or valacyclovir) 24 hours before vaccination (avoid use of these antiviral drugs for 14 days after vaccination
-Use of aspirin or aspirin-containing products
-Moderate or severe acute illness with or without fever
-If using MMRV, see MMR/MMRV for additional precautions

62
Q

COVID-19

A

-1vCOV-mRNA: Comirnaty/Pfizer-BioNTech COVID-19 Vaccine; SPIKEVAX/Moderna COVID-19 Vaccine
-2vCOV-mRNA: Pfizer-BioNTech COVID-19 Vaccine, Bivalent; Moderna COVID-19 Vaccine, Bivalent
-1vCOV-apS: Novavax COVID-19 Vaccine
-

63
Q

DEN4CYD

A

-Dengue vaccine
-Dengvaxia

64
Q

DTap

A

-Diphtheria, tetanus, and acellular pertussis vaccine
-Daptacel; Infanrix

65
Q

DT

A

-Diphtheria, tetanus vaccine
-No Trade Name

66
Q

Hib (PRP-T)

A

-Haemophilus influenzae type B vaccine
-ActHIB; Hiberix

67
Q

Hib (PRP-OMP)

A

-Haemophilus influenza type B vaccine
-PedvaxHIB

68
Q

HepA

A

-Hepatitis A vaccine
-Havrix; Vaqta

69
Q

HepB

A

-Hepatitis B vaccine
-Engerix-B; Recombivax HB

70
Q

HPV

A

-Human papillomavirus vaccine
-Gardasil 9

71
Q

IIV4

A

-Influenza vaccine (inactivated)
-Multiple

72
Q

LAIV4

A

-Influenza vaccine (live, attenuated)
-FluMist Quadrivalent

73
Q

MMR

A

-Measles, mumps, and rubella vaccine
-M-M-R II; Priorix

74
Q

MenACWY-D

A

-Meningococcal serogroups A, C, W, Y vaccine
-Menactra

75
Q

MenACWY-CRM

A

-Meningococcal serogroups A, C, W, Y vaccine
-Menveo

76
Q

MenACWY-TT

A

-Meningococcal serogroups A, C, W, Y vaccine
-MenQuadfi

77
Q

MenB-4C

A

-Meningococcal serogroup B vaccine
-Bexsero

78
Q

MenB-FHbp

A

-Meningococcal serogroup B vaccine
-Trumenba

79
Q

PCV13

A

-Pneumococcal conjugate vaccine
-Prevnar 13

80
Q

PCV15

A

-Pneumococcal conjugate vaccine
-Vaxneuvance

81
Q

PPSV23

A

-Pneumococcal polysaccharide vaccine
-Pneumovax 23

82
Q

IPV

A

-Poliovirus vaccine (inactivated)
-IPOL

83
Q

RV1
RV5

A

-Rotavirus
-Rotarix; RotaTeq

84
Q

Tdap

A

-Tetanus, diphtheria, and acellular pertussis vaccine
-Adacel; Boostrix

85
Q

Td

A

-Tetanus and diphtheria vaccine
-Tenivac; TDvax

86
Q

VAR

A

-Varicella vaccine
-Varivax

87
Q

Pediarix

A

-Combination vaccine
-Dtap-HepB-IPV

88
Q

Pentacel

A

-Combination vaccine
-DTaP-IPV/Hib

89
Q

Kinrix; Quadracel

A

-Combination vaccine
-DTaP-IPV

90
Q

Vaxelis

A

-Combination vaccine
-DTaP-IPV-Hib-HepB

91
Q

ProQuad

A

-Combination vaccine
-MMRV

92
Q

Moderna and children

A

Children ages six months to five years can receive two doses of Moderna in the primary series, given within 4-8 weeks apart

93
Q

Pfizer-BioNTech and children

A

Children six months to 4 years old receiving Pfizer will require three doses of the vaccine in the primary series
-both first and second doses should be separated by three to eight weeks, and the second and third doses should be separated by at least eight weeks
-children receiving Pfizer who are over age of five, will require two doses of Pfizer-BioNTech vaccine given eight weeks apart

94
Q

herd immunity

A

85% of population vaccinated

95
Q

Active immunity

A

resistance developed in response to infection with an agent resulting in antibody production
-active immunity is usually permanent
-can be either naturally acquired through exposure and infection with the disease or artificially acquired through immunization
-onset is 2-4 weeks and duration is years to lifetime

96
Q

Passive immunity

A

A person is given antibodies to a disease rather than producing them through his or her own immune system
-this is short term immunity through introduction of antibodies to a disease
-can occur naturally as in the passage of antibodies from the mother to the fetus during pregnancy or artificially acquired through injection of antibodies such as gamma globulin
-Onset is within 24 hours of the dose and duration is about 4-6 months

97
Q

Herd immunity

A

This occurs when a significant portion of the population is vaccinated and that provides a portion of immunity for those that have not developed immunity
-the population (herd) helps prevent disease in the unprotected population
-the herd protects those who cannot safely get vaccinations
-generally 90-95% of the population should be vaccinated to have effective herd immunity

98
Q

Vaccine Contraindications:
I-P-A “beer”

A

IPV, PCV13, HepA = defer mod-severe illness

99
Q

Vaccine Contraindications:
“A Painful Vaccine To Me”

A

HepA, PCV13, Varicella, Tdap, Meningococcal = minor site rxn

100
Q

Vaccine Contraindications:
The Mental Defects Matter

A

Tdap, MMR, DTaP, Meningococcal = defer neuro; febrile seizures

101
Q

Vaccine Contraindications:
Baby Is Happy

A

HepB, IPV, HiB = no reaction

102
Q

Vaccine Contraindications:
“Vagina IZ A Hateful Monster”

A

Varicella, IPV, Zoster, HepA, HPV, MMR

103
Q

Vaccine Contraindications:
allergic to yeast

A

HepB

104
Q

Vaccine Contraindications:
Type 1 egg allergy

A

Influenza

105
Q

Vaccine Contraindications:
GI issues/intussception

A

Rotavirus

106
Q

Vaccine Contraindications:
Neomycin

A

MMR, IPV

107
Q

Vaccine Contraindications:
Streptomycin/Polymyxin B

A

IPV

108
Q

Vaccine Contraindications:
Gelatin/Latex

A

MMR

109
Q

Vaccine Contraindications:
HIV

A

HepB, Influenza, PCV13, Tdap (w/Td given every 10 years - repeat) - protect against respiratory issues; don’t give HVI patient live viruses

CMN571 (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions